Enabling the Nervous System to Repair Itself

We create innovative solutions for the treatment of nervous system damage due to trauma or disease.

NervGen Pharma

NervGen is a publicly traded (TSX-V: NGEN, OTCQX: NGENF) clinical stage biotech company dedicated to developing novel drugs for the treatment of spinal cord injury, multiple sclerosis and Alzheimer’s disease.

Stay Connected

Sign up to our newsletter

The NervGen Story

In this inspiring and heartfelt video, Dr. Jerry Silver, Professor of Neurosciences, Case Western Reserve University, shares his journey and how the research carried out in his lab led to the formation of NervGen.

The video highlights how NervGen is developing Dr. Silver’s foundational discoveries into a disruptive technology that is aimed at changing the paradigm of how nervous system damage will be treated.



News Release